Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people who experience side effects on day 1 of Mounjaro notice them within a few hours of the injection — typically mild nausea, a reduced appetite, or a vague feeling of fullness that lingers longer than usual. These reactions are common at the 2.5mg starting dose, are usually short-lived, and generally ease within days as your body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins, and how those early effects develop is something they'll want to know about as your treatment progresses.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've done the injection, probably in your abdomen or thigh, just as the Patient Information Leaflet describes. Within a couple of hours, something shifts. Food doesn't look quite as appealing as it did. You might feel faintly queasy, or notice a heaviness in your stomach after only a small amount to eat. Some people feel fine entirely.
This is the territory that most Mounjaro day 1 side effects occupy. Nausea is the most common, followed by a feeling of fullness, mild indigestion, or occasional loose stools. A few people mention a brief headache or low-level fatigue by evening. These aren't signs that something has gone wrong, they reflect how tirzepatide works. It slows gastric emptying, meaning food moves through your stomach more slowly than your body is used to. Day 1 is, for most people, the steepest part of the adjustment curve.
Small, low-fat meals help. Avoiding rich or fried food on injection day is a practical move most prescribers suggest. Staying well hydrated matters too, especially if nausea makes eating feel unappealing. A fuller picture of Mounjaro's side-effect profile covers what tends to happen across the whole first month, not just the first day.
One thing worth acknowledging: if you've been looking forward to starting treatment and then feel rough on day 1, that's genuinely disheartening. The good news is that the pattern in clinical trials (and in the experience our prescribers hear described most weeks) is that these early effects settle considerably by weeks two and three, particularly at the starting dose.
Tirzepatide activates two gut-hormone receptors at once (GIP and GLP-1) which is what makes Mounjaro a dual-agonist and distinguishes it from other weight-management injections. Both pathways influence appetite signals in the brain and slow the rate at which the stomach empties. The nausea and fullness that many people notice on day 1 are essentially those mechanisms doing exactly what they're supposed to do, hitting a system that hasn't encountered them before.
The 2.5mg first dose is calibrated specifically for this moment. It isn't the dose at which most of the trial weight-loss results were achieved; it exists so that your digestive system has a chance to adapt before the dose rises. The NHS patient information for tirzepatide outlines what's expected at each stage of treatment.
Injection-site reactions (a brief sting, mild redness, or a small lump under the skin) are also possible on day 1. Rotating the injection site each week and allowing the pen to reach room temperature before use can reduce these. Most injection-site effects resolve within a day or two and rarely need any treatment.
If you want to read ahead about how these effects typically evolve, day 2 and day 3 are worth looking at, the trajectory from here is usually better, not worse.
Most day 1 side effects don't require medical attention. Some do. Knowing the difference matters.
Get urgent help (from a GP, 111, or A&E depending on severity) if you experience any of the following after your first dose:
If you're troubled by something that doesn't fit those categories (persistent mild nausea, discomfort, uncertainty about whether what you're experiencing is normal) our prescribers are available seven days a week as part of your aftercare. You can also get in touch with the team if you're not sure where to start.
Any suspected side effect, including one on day 1, can be reported directly to the MHRA through the Yellow Card scheme. You don't need to wait for a formal diagnosis to file a report, if you think a medicine caused something, they want to know.
The first injection covers seven days. For most people, the intensity of any nausea or GI discomfort is front-loaded, strongest in the first 24–48 hours, then gradually easing. By days 4 to 7, many people report that the side effects have dropped off substantially, and appetite reduction (which is the intended effect) starts to feel more like a settled background rather than an acute feeling.
That said, the pattern varies. A small number of people feel very little on day 1 and notice more on days 2 or 3 as the drug's levels build. The tirzepatide day 1 experience page looks at this from a slightly different angle if you want more context on why individual responses differ.
The most useful thing to do in week 1 is keep a brief note of what you notice and when, not to alarm yourself, but so that when your prescriber reviews your treatment before the next dose, you have something concrete to share. Dose increases in tirzepatide are a clinical decision, and how you tolerate the starting dose feeds directly into that. You can read more about the broader experience on our first-day side effects overview, or explore what medically supervised weight-loss treatment actually involves day to day.
If you haven't yet started treatment and are weighing up options, our prescribers discuss both suitability and the side-effect picture during the consultation. Check your eligibility to begin that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.